{
    "title": "STAT2 signaling as double-edged sword restricting viral dissemination but driving severe pneumonia in SARS-CoV-2 infected hamsters",
    "author": "Microsoft Office User",
    "date": 2020,
    "affiliations": [
        "KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, B-3000 Leuven, Belgium",
        "Molecular Vaccinology and Vaccine Discovery Group",
        "Translational Platform Virology and Chemotherapy",
        "Department of Animal, Dairy, and Veterinary Sciences, Utah State University, UT 84322-4815 Logan, Utah, United States of America 5 KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Clinical and Epidemiological Virology, B-3000 Leuven, Belgium",
        "Zoonotic Infectious Diseases Unit",
        "Laboratory of Viral Metagenomics 8 KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, B-3000 Leuven, Belgium 9 KU Leuven Department of Imaging and Pathology, Biomedical MRI and MoSAIC, B-3000 Leuven, Belgium 10 KU Leuven Department of Imaging and Pathology, Nuclear Medicine and Molecular Imaging and MoSAIC, B-3000 Leuven, Belgium",
        "Division of Nuclear Medicine, University Hospitals Leuven, B-3000 Leuven, Belgium",
        "Division of Translational Cell and Tissue Research 13 KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute, Immunity and Inflammation Research Group, Immunobiology Unit, B-3000 Leuven, Belgium 14 KU Leuven Department of Laboratory Medicine, University Hospitals Leuven, B-3000 Leuven, Belgium",
        "National Reference Center for Respiratory Pathogens and Enteroviruses, B-3000 Leuven, Belgium",
        "Leuven University Vaccinology Center (LUVAC), 3000 Leuven, Belgium 17 KU Leuven Department of Clinical and Experimental Medicine, Division of Respiratory Diseases, University Hospitals Leuven, B-3000 Leuven, Belgium"
    ],
    "journal": "SARS",
    "volume": "2",
    "identifiers": {
        "arxiv": null,
        "doi": "10.1101/2020.04.23.056838",
        "isbn": null,
        "doc_id": null,
        "url": "http://biorxiv.org/cgi/content/short/2020.04.23.056838.pdf"
    },
    "keywords": [
        "SARS-CoV-2 (2019-nCoV)",
        "COVID-19",
        "animal models",
        "pneumonia",
        "innate immunity",
        "STAT2",
        "IL28R",
        "type I and III interferons",
        "immune pathogenesis",
        "micro-CT"
    ],
    "funding": [
        {
            "award-group": [
                {
                    "funding-source": "European Union\u2019s Horizon",
                    "award-id": [
                        "101003627"
                    ]
                },
                {
                    "funding-source": "SCORE",
                    "award-id": [
                        "733176",
                        "RABYD-VAX consortium"
                    ]
                },
                {
                    "funding-source": "Research Foundation Flanders"
                },
                {
                    "funding-source": "Excellence of Science",
                    "award-id": [
                        "VirEOS project 30981113"
                    ]
                },
                {
                    "funding-source": "VirEOS project",
                    "award-id": [
                        "30981113"
                    ]
                },
                {
                    "funding-source": "FWO Hercules Foundation",
                    "award-id": [
                        "Caps-It infrastructure"
                    ]
                },
                {
                    "funding-source": "KU Leuven Rega Foundation,"
                },
                {
                    "funding-source": "Stichting Antoine Faes"
                }
            ],
            "funding-statement": "This project has received funding from the European Union\u2019s Horizon 2020 research and innovation program under grant agreements No 101003627 (SCORE project) and No 733176 (RABYD-VAX consortium), and was supported by the Research Foundation Flanders (FWO) under the Excellence of Science (EOS) program (VirEOS project 30981113), the FWO Hercules Foundation (Caps-It infrastructure), the KU Leuven Rega Foundation, and the Stichting Antoine Faes"
        },
        {
            "award-group": [
                {
                    "funding-source": "China Scholarship Council"
                }
            ],
            "funding-statement": "J.M. was supported by a grant from the China Scholarship Council (CSC)"
        },
        {
            "award-group": [
                {
                    "award-id": [
                        "FWO 1001719N"
                    ]
                }
            ],
            "funding-statement": "C.C. was supported by the FWO (FWO 1001719N)"
        },
        {
            "award-group": [
                {
                    "funding-source": "KU Leuven Internal Funds",
                    "award-id": [
                        "C24/17/061"
                    ]
                },
                {
                    "funding-source": "KU Leuven Internal Funds",
                    "award-id": [
                        "C3/19/057"
                    ]
                },
                {
                    "funding-source": "Lab of Excellence)"
                }
            ],
            "funding-statement": "G.V.V. acknowledges grant support from KU Leuven Internal Funds (C24/17/061) and K.D. grant support from KU Leuven Internal Funds (C3/19/057 Lab of Excellence)"
        },
        {
            "award-group": [
                {
                    "funding-source": "KU Leuven and FWO-Vlaanderen"
                }
            ],
            "funding-statement": "G.O. and E.M. were supported by C16/17/010 funding from KU Leuven and FWO-Vlaanderen"
        }
    ]
}